Treatment time, chronic inflammation, and hemodynamic stability: The overlooked parameters in hemodialysis quantification

Seminars in Dialysis

Volumn 21, Issue 5, 2008, Pages 395-400

  Zsom, Lajos ^a   Zsom, Marianna ^b   Fulop, Tibor ^a   Flessner, Michael F ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b Diaverum Dialysis Center   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; HEMODIALYSIS FLUID; UREA;

ARTICLE; BLOOD PRESSURE; BLOOD VOLUME; CHRONIC KIDNEY FAILURE; HUMAN; METABOLISM; METHODOLOGY; MORTALITY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RENAL REPLACEMENT THERAPY; TIME;

ACUTE-PHASE PROTEINS; BLOOD PRESSURE; BLOOD VOLUME; HEMODIALYSIS SOLUTIONS; HUMANS; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS; TIME FACTORS; UREA;

EID: 54749106601     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2008.00488.x     Document Type: Article

References (79)

1. Sargent JA, Gotch FA : The analysis of concentration dependence of uremic lesions in clinical studies. Kidney Int Suppl, 7 : S35 S446, 1975
2. United States Renal Data System : 2007 Annual Data Report: Atlas of End Stage Renal Disease in the United States, Chapter 5, Clinical Indicators, p 124 Chapter 6, Morbidity & Mortality, p 138. Bethesda, MD : National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2007 http://www.usrds.org/atlas.htm
3. Saran R, Bragg-Gresham JL, Levin NW, Twardowski ZJ, Wizemann V, Saito A, Kimata N, Gillespie BW, Combe C, Bommer J, Akiba T, Mapes DL, Young EW, Port FK : Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int 69 (7 1222 1228, 2006
4. Shinzato T, Nakai S, Akiba T, Yamazaki C, Sasaki R, Kitaoka T, Kubo K, Shinoda T, Kurokawa K, Marumo F, Sato T, Maeda K : Survival in long-term hemodialysis patients: results from the annual survey of the Japanese Society for dialysis therapy. Nephrol Dial Transplant 12 : 884 888, 1997
5. Charra B, Terrat JC, Vanel T, Chazot C, Jean G, Hurot JM, Lorriaux C : Long thrice weekly hemodialysis: the Tassin experience. Int J Artif Organs 27 (4 265 283, 2004
6. Marshall MR, Byrne BG, Kerr PG, McDonald SP : Associations of hemodialysis dose and session length with mortality risk in Australian and New Zealand patients. Kidney Int 69 (7 1229 1236, 2006
7. Johnson WJ, Hagge WW, Wagoner RD, Dinapoli RP, Rosevear JW : Effects of urea loading in patients with far-advanced renal failure. Mayo Clinic Proc 47 : 21 29, 1972
8. Dhondt A, Vanholder R, VanBiesen W, Lameire N : The removal of uremic toxins. Kidney Int 58 (Suppl 76 pp. S-47 S-59, 2000
9. Held PJ, Port FK, Wolfe RA, Stannard DC, Carroll CE, Daugirdas JT, Bloembergen WE, Greer JW, Hakim RM : The dose of hemodialysis and patient mortality. Kidney Int 50 : 550 556, 1996
10. Hakim RM, Breyer J, Ismail N, Schulman G : Effects of dose of dialysis on morbidity and mortality. Am J Kidney Dis 23 : 661 669, 1994
11. Husn L, Huang W, Lew N, Lowrie E : Survival of hemodialysis in the U.S. is improved with a greater quantity of dialysis. Am J Kidney Dis 23 : 670 680, 1994
12. Lowrie EG, Laird NM : The National Cooperative Dialysis Study. Kidney Int 23 (Suppl 13 S1 S122, 1983
13. Brunner FP : End-stage renal failure due to diabetic nephropathy: data from EDTA registry. J Diabet Complications 2 : 127 137, 1989
14. Held PJ, Port FK, Webb RL : Excerpts from the United States Renal Data System 1996 Annual Report. Am J Kidney Dis 28 : S79 S92, 1996
15. Parker TF, Laird NM, Lowrie EG : Comparison of the study groups in the National Cooperative Dialysis Study and a description of morbidity, mortality and patient withdrawal. Kidney Int 23 (Suppl 13 S42 S49, 1983
16. Gotch FA, Sargent JA : A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 28 : 526 534, 1985
17. Keshaviah P : Urea kinetic and middle molecule approaches to assessing the adequacy of hemodialysis and CAPD. Kidney Int 40 : S28 S38, 1993
18. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R, Hemodialysis (HEMO) Study Group : Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347 (25 2010 2019, 2002
19. McCusker FX, Teehan BP, Thorpe KE, Keshaviah PR, Churchill DN : How much peritoneal dialysis is required for the maintenance of a good nutritional state? Canada-USA (CANUSA) Peritoneal Dialysis Study Group. Kidney Int Suppl 56 : S56 S61, 1996
20. Bargman JM, Thorpe KE, Churchill DN, CANUSA Peritoneal Dialysis Study Group : Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol 12 (10 2158 2162, 2001
21. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, Mujais S, Mexican Nephrology Collaborative Study Group : Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 13 (5 1307 1320, 2002
22. Held PJ, Brunner F, Garcia Jr. OM, Port FK, Gaylin DS : Five-year survival for end stage renal disease patients in the United States, Europe and Japan, 1982 to 1987. Am J Kidney Dis 15 : 451 457, 1990
23. Marcelli D, Stannard D, Conte F, Held PJ, Locatelli F, Port FK : ESRD patient mortality with adjustment for comorbid conditions in Lombardy (Italy) versus the United States. Kidney Int 50 : 1013 1018, 1996
24. Kalantar-Zadeh K, Kilpatrick RD, Kuwael N, McAllister CJ, Alcorn H Jr., Kopple JD, Greenland S : Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction. Nephrol Dial Transplant 20 9 1880 1888, 2005
25. Owen WF, Lew NL, Liu Y, Lowrie EG, Lazarus JM : The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 329 : 1001 1006, 1993
26. Is K, Kawazoe N, Fukiyama K : Serum albumin is a strong predictor of death in chronic dialysis patients. Kidney Int 44 : 115 119, 1993
27. Fung F, Sherrard DJ, Gillen DL, Wong C, Kestenbaum B, Seliger S, Ball A, Stehman-Breen C : Increased risk for cardiovascular mortality among malnourished end-stage renal disease patients. Am J Kidney Dis 40 (2 307 314, 2002
28. Cooper BA, Penne EL, Bartlett LH, Pollock CA : Protein malnutrition and hypoalbuminemia as predictors of vascular events and mortality in ESRD. Am J Kidney Dis 43 (1 61 66, 2004
29. Lowrie EG, Lew NL : Death risk in hemodialysis patients. The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15 : 458 482, 1990
30. Beddhu S, Cheung AK, Larive B, Greene T, Kaysen GA, Levey AS, Rocco M, Sarnak M, Toto R, Eknoyan G, Hemodialysis (HEMO) Study Group : Inflammation and inverse associations of body mass index and serum creatinine with mortality in hemodialysis patients. J Ren Nutr 17 (6 372 380, 2007
31. Kaysen GA, Rathore V, Shearer GC, Depner TA : Mechanisms of hypoalbuminemia in hemodialysis patients. Kidney Int 48 : 510 516, 1995
32. Kaysen GA, Don BR : Factors that affect albumin concentration in dialysis patients and their relationship to vascular disease. Kidney Int Suppl 84 : S94 S97, 2003
33. Kaysen GA, Chertow GM, Adhikarla R, Young B, Ronco C, Levin NW : Inflammation and dietary protein intake exert competing effects on serum albumin and creatinine in hemodialysis patients. Kidney Int 60 (1 333 340, 2001
34. Lee CT, Lee CH, Su Y, Chuang YC, Tsai TL, Cheni JB : The relationship between inflammatory markers, leptin and adiponectin in chronic hemodialysis patients. Int J Artif Organs 27 (10 835 841, 2004
35. Menon V, Wang X, Greene T, Beck GJ, Kusek JW, Marcovina SM, Levey AS, Sarnak MJ : Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease. Am J Kidney Dis 42 (1 44 52, 2003
36. Bologa RM, Levine DM, Parker TS, Cheigh JS, Serur D, Stenzel KH, Rubin AL : Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis 32 : 107 114, 1998
37. Honda H, Qureshi AR, Heimbürger O, Barany P, Wang K, Pecoits-Filho R, Stenvinkel P, Lindholm B : Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis 47 (1 139 148, 2006
38. Qureshi AR, Alvestrand A, Danielsson A, Divino-Filho JC, Gutierrez A, Lindholm B, Bergström J : Factors predicting malnutrition in hemodialysis patients: a cross-sectional study. Kidney Int 53 (3 773 782, 1998
39. Kaysen GA, Greene T, Daugirdas JT, Kimmel PL, Schulman GW, Toto RD, Levin NW, Yan G, HEMO Study Group : Longitudinal and cross-sectional effects of C-reactive protein, equilibrated normalized protein catabolic rate, and serum bicarbonate on creatinine and albumin levels in dialysis patients. Am J Kidney Dis 42 (6 1200 1211, 2003
40. Kalantar-Zadeh K : Inflammatory marker mania in chronic kidney disease: pentraxins at the crossroad of universal soldiers of inflammation. Clin J Am Soc Nephrol 2 (5 872 875, 2007
41. Korevaar CJ, van Manen JG, de Waart DR, Krediet RT : Effect of an increase in C-reactive protein level during a hemodialysis session on mortality. J Am Soc Nephrol 15 : 2916 2922, 2004
42. Yeun JY, Levine RA, Mantadilok V, Kaysen GA : C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 35 : 469 476, 2000
43. Apple FS, Murakami MM, Pearce LA, Herzog CA : Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death. Clin Chem 50 (12 2279 2285, 2004
44. Stenvinkel P, Ketteler M, Johnson RJ, Lindholm B, Pecoits-Filho R, Riella M, Heimbürger O, Cederholm T, Girndt M : IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia: the good, the bad, and the ugly. Kidney Int 67 (4 1216 1233, 2005
45. Stenvinkel P, Alvestrand P : Inflammation in end-stage renal disease: sources, consequences and therapy. Semin Dial 15 : 330 338, 2002
46. Cappelli G, Tetta C, Canaud B : Is biofilm a cause of silent chronic inflammation in haemodialysis patients? A fascinating working hypothesis. Nephrol Dial Transplant 20 (2 266 270, 2005
47. Ortega O, Gallar P, Muñoz M, Rodríguez I, Carreño A, Ortiz M, Molina A, Oliet A, Lozano L, Vigil A : Association between C-reactive protein levels and N-terminal pro-B-type natriuretic peptide in pre-dialysis patients. Nephron Clin Pract 97 (4 c125 c130, 2004
48. Avila-Díaz M, Ventura MD, Valle D, Vicenté-Martínez M, García-González Z, Cisneros A, Furlong MD, Gómez AM, Prado-Uribe MD, Amato D, Paniagua R : Inflammation and extracellular volume expansion are related to sodium and water removal in patients on peritoneal dialysis. Perit Dial Int 26 (5 574 580, 2006
49. Gutierrez A, Bergström J, Alvestrand A : Protein catabolism in sham-hemodialysis: the effect of different membranes. Clin Nephrol 38 (1 20 29, 1992
50. Caglar K, Peng Y, Pupim LB, Flakoll PJ, Levenhagen D, Hakim RM, Ikizler TA : Inflammatory signals associated with hemodialysis. Kidney Int 62 (4 1408 1416, 2002
51. McIntyre CW, Burton JO, Selby NM, Leccisotti L, Korsheed S, Baker CS, Camici PG : Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow. Clin J Am Soc Nephrol 3 : 19 26, 2007
52. Zhou YL, Liu HL, Duan XF, Yao Y, Sun Y, Liu Q : Impact of sodium and ultrafiltration profiling on hemodialysis-related hypotension. Nephrol Dial Transplant 21 : 3231 3237, 2006
53. Selby NM, McIntyre CW : The acute cardiac effects of dialysis. Semin Dial 20 (3 220 228, 2007
54. van der Sande FM, Kooman JP, Leunissen KM : Strategies for improving hemodynamic stability in cardiac compromised dialysis patients. Am J Kidney Dis 35 : E19, 2000
55. Shoji T, Tsubakihara Y, Fujii M, Imai E : Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients. Kidney Int 66 : 1212 1220, 2004
56. Rubinger D, Revis N, Pollak A, et al. : Predictors of haemodynamic instability and heart rate variability during haemodialysis. Nephrol Dial Transplant 19 : 2053 2060, 2004
57. Zager PG, Nikolic J, Brown RH, et al. : "U" curve association of blood pressure and mortality in hemodialysis patients. Kidney Int 54 : 561 569, 1998
58. Iseki K, Miyasato F, Tokuyama K, et al. : Low diastolic blood pressure, hypoalbuminemia, and risk of death in a cohort of chronic hemodialysis patients. Kidney Int 51 : 1212 1217, 1997
59. Jansen MA, Hart AA, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT, for the NECOSAD Study Group : Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int 62 : 1046 1053, 2002
60. Wang AY, Wang M, Woo J, et al. : Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients. J Am Soc Nephrol 15 : 2186 2194, 2004
61. Termorshuizen F, Dekker FW, van Manen JG, Korevaar JC, Boeschoten EW, Krediet RT : Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. J Am Soc Nephrol 15 : 1061 1070, 2004
62. Sherman RA : Modifying the dialysis prescription to reduce intradialytic hypotension. Am J Kidney Dis 38 (Suppl 4 S18 S25, 2001
63. Scribner BH, Dialysis Therapy in the United States : A historical perspective. Home Hemodial Int 3 : 9 12, 1999
64. Locatelli F, Manzoni C : Duration of dialysis sessions - was Hegel right? Nephrol Dial Transplant 14 : 560 563, 1999
65. Twardowski ZJ : Short, thrice-weekly hemodialysis is inadequate regardless of small molecule clearance. Int J Artif Organs. 27 (6 452 466, 2004
66. Charra B, Calemard M, Laurent G : Importance of treatment time and blood pressure control in achieving long-term survival on dialysis. Am J Nephrol 16 : 35 44, 1996
67. Chan CT, Jain V, Picton P, Pierratos A, Floras JS : Nocturnal hemodialysis increases arterial baroreflex sensitivity and compliance and normalizes blood pressure of hypertensive patients with end-stage renal disease. Kidney Int 68 (1 338 344, 2005
68. Kooistra MP, Vos J, Koomans HA, Vos PF : Daily home haemodialysis in The Netherlands: effects on metabolic control, haemodynamics, and quality of life. Nephrol Dial Transplant 13 : 2853 2860, 1998
69. Ozkahya M, Ok E, Toz H, Asci G, Duman S, Basci A, Kose T, Dorhout Mees EJ : Long-term survival rates in haemodialysis patients treated with strict volume control. Nephrol Dial Transplant 21 : 3506 3513, 2006
70. Charra B : From adequate to optimal dialysis long 3 × 8 hr dialysis: a reasonable compromise. Nefrologia 25 (Suppl 2 19 24, 2005
71. Raj DS, Charra B, Pierratos A, Work J : In search of ideal hemodialysis: is prolonged frequent dialysis the answer? Am J Kidney Dis 34 (4 597 610, 1999
72. Thomas A : Depner. Uremic Toxicity: Urea and Beyond. Semin Dial. 14 (4 246 251, 2001
73. Moore FD, McMurray JD, Parker HV, Magnus IC : Total body water and electrolytes: Intravascular and extravascular phase volumes. Metabolism 10 : 447 467, 1956
74. Bammens B, Evenepoel P, Verbeke K, Vanrentherghem Y : Removal of middle molecules and protein-bound solutes by peritoneal dialysis and relation with uremic symptoms. Kidney Int 64 : 2238 2243, 2003
75. Noordzij M, Korevaar JC, Bos WJ, Boeschoten EW, Dekker FW, Bossuyt PM, Krediet RT : Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients. Nephrol Dial Transplant 21 (9 2513 2520, 2006
76. Ayus JC, Achinger SG, Mizani MR, Chertow GM, Furmaga W, Lee S, Rodriguez F : Phosphorus balance and mineral metabolism with 3 h daily hemodialysis. Kidney Int 71 : 336 342, 2007
77. Suda T, Hiroshige K, Ohta T, Watanabe Y, Iwamoto M, Kanegae K, Ohtani A, Nakashima Y : The contribution of residual renal function to overall nutritional status in chronic haemodialysis patients. Nephrol Dial Transplant 15 : 396 401, 2000
78. Shemin D, Bostom AG, Laliberty P, Dworkin LD : Residual renal function and mortality risk in hemodialysis patients. Am J Kidney Dis 38 : 85 90, 2001
79. Chazot C, Vo-Van C, Blanc C, Hurot JM, Jean G, Vanel T, Terrat JC, Charra B : Stability of nutritional parameters during a 5-year follow-up in patients treated with sequential long-hour hemodialysis. Hemodial Int 10 (4 389 393, 2006